跳至主要内容
临床试验/NCT00910338
NCT00910338已完成不适用

Efficacy and Safety of Extracorporeal Biofeedback Pelvic Floor Muscle Training to Treat Urodynamic Stress Incontinence

KYU-SUNG LEE3 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2007年7月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
KYU-SUNG LEE
入组人数
100
试验地点
3
主要终点
Cure rate according to standard pad test ; Cure is defined as less than 2g on the standard pad test.

研究概览

简要总结

Stress urinary incontinence is the most common type of female incontinence. The efficacy of pelvic floor muscle training with biofeedback has been already proved in many studies. But intravaginal probe is one of the limitation. So, the purpose of this study is to assess the efficacy and safety of extracorporeal biofeedback device with pelvic floor muscle training.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women with stress urinary incontinence
  • Standard pad test > 2gram

排除标准

  • Women with:
  • Mixed urinary incontinence of which urgency incontinence is dominant
  • True incontinence
  • Overflow incontinence
  • Treatment within 14 days preceding screening, or expected to initiate treatment during the study with electrostimulation, bladder training
  • Treatment within 7 days preceding screening, or expected to initiate treatment during the study with OAB medication or other medication which affect bladder function
  • Pelvic organ prolapse which the stage is at least 2
  • Proven urinary tract infection during screening period
  • Pacemaker
  • Pregnant women
  • Neurogenic voiding dysfunction

结局指标

主要结局

Cure rate according to standard pad test ; Cure is defined as less than 2g on the standard pad test.

时间窗: After 12 weeks of treatment

次要结局

  • Change in Incontinence severity VAS (I-VAS), Sandvik questionnaire, Incontinence Quality of Life (I-QoL), and Pelvic Floor Muscle Strength.(After 12 weeks of treatment)
  • Patient perception of Treatment Benefit, Satisfaction, Willingness to Retreatment/Recommendation (BSW).(After 12 weeks of treatment)

研究者

发起方
KYU-SUNG LEE
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

KYU-SUNG LEE

professor

Samsung Medical Center

研究点 (3)

Loading locations...

相似试验